Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

First siRNA Therapy Approved for Myasthenia Gravis

(MedPage Today) -- The FDA approved subcutaneous cemdisiran (Livsayis), a small interfering RNA (siRNA) therapy, to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody-positive, Regeneron announced...

First siRNA Therapy Approved for Myasthenia Gravis

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 19 November →